Trial · NCT00007475
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | FPF NOT Assayed, Plasma Exchange + Cyclophosphamide Completed | 12 | |
| Overall Study | STARTED | FPF Assayed Pre-Tx as Low, PE + Cyclophosphamide Completed | 1 | |
| Overall Study | STARTED | FPF Assayed Pre-Tx as High, PE + Cyclophosphamide Completed | 2 | |
| Overall Study | STARTED | Historical Controls | 0 | |
| Overall Study | FSGS Permeability Factor (FPF) Assayed | FPF NOT Assayed, Plasma Exchange + Cyclophosphamide Completed | 0 | |
| Overall Study | FSGS Permeability Factor (FPF) Assayed | FPF Assayed Pre-Tx as Low, PE + Cyclophosphamide Completed | 1 | |
| Overall Study | FSGS Permeability Factor (FPF) Assayed | FPF Assayed Pre-Tx as High, PE + Cyclophosphamide Completed | 2 | |
| Overall Study | FSGS Permeability Factor (FPF) Assayed | Historical Controls | 0 | |
| Overall Study | Initial Transplant | FPF NOT Assayed, Plasma Exchange + Cyclophosphamide Completed | 12 | |
| Overall Study | Initial Transplant | FPF Assayed Pre-Tx as Low, PE + Cyclophosphamide Completed | 1 | |
| Overall Study | Initial Transplant | FPF Assayed Pre-Tx as High, PE + Cyclophosphamide Completed | 2 | |
| Overall Study | Initial Transplant | Historical Controls | 0 | |
| Overall Study | Post-initial Transplant Proteinuria | FPF NOT Assayed, Plasma Exchange + Cyclophosphamide Completed | 12 | |
| Overall Study | Post-initial Transplant Proteinuria | FPF Assayed Pre-Tx as Low, PE + Cyclophosphamide Completed | 1 | |
| Overall Study | Post-initial Transplant Proteinuria | FPF Assayed Pre-Tx as High, PE + Cyclophosphamide Completed | 2 | |
| Overall Study | Post-initial Transplant Proteinuria | Historical Controls | 0 | |
| Overall Study | Initial Plasma Exchange | FPF NOT Assayed, Plasma Exchange + Cyclophosphamide Completed | 12 | |
| Overall Study | Initial Plasma Exchange | FPF Assayed Pre-Tx as Low, PE + Cyclophosphamide Completed | 1 | |
| Overall Study | Initial Plasma Exchange | FPF Assayed Pre-Tx as High, PE + Cyclophosphamide Completed | 2 | |
| Overall Study | Initial Plasma Exchange | Historical Controls | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00007475/flow